Roche, drugmakers jump as bird flu threatens America (Business Day) April 28 – Bird flu has been a boon for money-losing drugmaker Novavax. In the two years ended in August 2005, its stock price plummeted 87 percent. That spurred Malvern, Pennsylvania-based Novavax to focus on developing an avian flu vaccine. [News Source]